Clinical Trials
101 trialsRare CNS Tumors Outcomes &Risk
National Institutes of Health Clinical Center (CC)
Multimodal Machine Learning Characterization of Solid Tumors
Massachusetts General Hospital
[18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related Changes
Telix Pharmaceuticals (Innovations) Pty Limited
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients
InSightec
UFGAG
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Natural History of and Specimen Banking for People With Tumors of the Central Nervous System
National Institutes of Health Clinical Center (CC)
C-SMART
Virginia Commonwealth University
Location-Molecular Integrated Outcomes in 450 Cerebellar Glioma Microsurgical Cases
West China Hospital
fMRI Reveal Functional Preservation in Glioma Peritumoral Edema
West China Hospital
FET-TREAT
Sunnybrook Health Sciences Centre
PROGLIO
Centre Jean Perrin
VERONICA
Huashan Hospital
ALBATROSS
Universitat Politècnica de València
BIOhabitats
Universitat Politècnica de València
RADDOPAG-2
Central Hospital, Nancy, France
Evaluation of Functional Magnetic Resonance Imaging (fMRI) in Patients Who Speak Two Languages Fluently
Memorial Sloan Kettering Cancer Center
PCNSL,GLIOMA
Guangdong Provincial People's Hospital
Whole-Brain Tumor Burden Metrics with Inflammatory and Molecular Markers to Predict Postoperative Neurocognitive Decline in Glioma
West China Hospital
MicroRNAs in Patients With Neurofibromatosis Type 1
Ann & Robert H Lurie Children's Hospital of Chicago
Measuring Fatty Acid Oxidation in Gliomas Using 18F-FPIA PET/MRI
Imperial College London
BraTioUS-DB
Hospital del Rio Hortega
Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma Patients
Novosibirsk State University
PRaM-GBM
Cambridge University Hospitals NHS Foundation Trust
Intraoperative Laser Speckle Contrast Imaging of Cerebral Blood Flow
Dynamic Light
Multimodal MR Imaging in Patients With Glioblastoma Treated With Dendritic Cell Therapy
Universitaire Ziekenhuizen KU Leuven
Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of Incident WHO II and III Grade Gliomas.
GCS Ramsay Santé pour l'Enseignement et la Recherche
NTRK Fusion
GCS Ramsay Santé pour l'Enseignement et la Recherche
Development and Validation of a Deep Learning-Based Survival Prediction Model for Pediatric Glioma Patients: A Retrospective Study Using the SEER Database and Chinese Data
Tang-Du Hospital
Social Determinants of Health in Glioblastoma Population
Wake Forest University Health Sciences
IDeATIon
Assistance Publique - HĂ´pitaux de Paris
2D-ioUS-Glio
Hospital del Rio Hortega
Quality of Life and Patient Needs in Advanced High Grade Gliomas
Henry Ford Health System
Molecular Pathology Research Project of Glioma
Huashan Hospital
Multi-center Research Project for Glioma Molecular Pathology Intraoperative Rapid Detection
Huashan Hospital
GLIOMA
Regina Elena Cancer Institute
Immunophenotyping From Blood of Patients With Malignant Gliomas
University of Erlangen-NĂĽrnberg Medical School
Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas
University of Texas Southwestern Medical Center
POG-C
University Hospital, Tours
RADDOPAG
Central Hospital, Nancy, France
Molecular Characterization of Gliomas Using a Broad Next Generation Sequencing (NGS)Panel
Hellenic Cooperative Oncology Group
Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas
H. Lee Moffitt Cancer Center and Research Institute
ALAglioma
Tata Memorial Hospital
Treatment Decision-making in Patients With Recurrent High-grade Glioma
Odense University Hospital
Clinical Development of MR Spectroscopy and Imaging in Brain Cancers
University of Texas Southwestern Medical Center
Clinical Evaluation of Genetron IDH1 PCR Kit in Glioma Patients
Genetron Health
Clinical Evaluation of Genetron TERT PCR Kit in Glioma Patients
Genetron Health
Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors
Wake Forest University Health Sciences
IDASPE
Institut National de la Santé Et de la Recherche Médicale, France
ACTION
Duke University
Validation of Readiband™ Actigraph and Associated Sleep/Wake Classification Algorithms
Allina Health System